Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

businesswire

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing – NEWSnet – News… as it used to be

More Press Releases

May 14, 2026

NowVertical Signs $4M Three-Year AI and Google Cloud Agreement with Leading Latin American Fintech

May 14, 2026

/C O R R E C T I O N — Driive Inc./

May 14, 2026

LVMH and WHP Global Announce Definitive Agreement for the Acquisition of Marc Jacobs

May 14, 2026

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

NowVertical Signs $4M Three-Year AI and Google Cloud Agreement with Leading Latin American Fintech

/C O R R E C T I O N — Driive Inc./

LVMH and WHP Global Announce Definitive Agreement for the Acquisition of Marc Jacobs

Kid Spark Education Expands Access to Early Childhood STEM & Literacy Through New Head Start Initiative